.svg)
Open Wound Research and Venture Medical Announce Collaboration to Advance Pressure Ulcer Research
.png)
Puyallup, WA – March 11, 2025 – Open Wound Research and Venture Medical, LLC have entered into a collaborative research agreement to advance the study of pressure ulcer treatment. As part of this partnership, Venture Medical has acquired extensive pressure ulcer data from Open Wound Research to evaluate the efficacy of CAMPS in comparison to standard of care (SOC) treatments.
Pressure ulcers, also known as pressure injuries or bedsores, remain a significant healthcare challenge, particularly for patients with limited mobility. Many patients suffer from hard-to-heal pressure ulcers that do not respond to extended SOC, requiring advanced treatments or alternative modalities. This research initiative aims to provide valuable insights into how CAMPS products can improve patient outcomes by enhancing wound healing.
“We are excited to collaborate with Venture Medical as their data partner on this important research,” said Zwelithini Tunyiswa, Chief Executive Officer at Open Wound Research. “By leveraging real-world data, we aim to generate clinically relevant findings that can help shape the future management of hard-to-heal pressure ulcers.”
As part of this collaboration, Open Wound Research and Venture Medical will work with leading researchers to assess the efficacy and efficiency of CAMPS products in pressure ulcer treatment. The findings are expected to contribute to evidence-based recommendations for healthcare providers treating pressure ulcer patients.
“This collaboration marks a significant step forward in our commitment to developing and distributing advanced solutions for wound care.” said John Schroeder, Chief Executive Officer at Venture Medical. “By comparing CAMPS product performance to SOC, we seek to provide healthcare professionals with data-driven insights to optimize patient care.”
The results of this research will be shared with the medical community through publications and conferences, ensuring that clinicians and researchers have access to the latest advancements in pressure ulcer treatment.
About Venture Medical, LLC: Venture Medical is a groundbreaking healthcare services company with a decade-long history of innovation, dedication, and consistent growth in the field of wound care and healing. Over the past 15 years, Venture Medical has expanded its reach across the United States and has grown to become a leading master distributor and reseller and software services provider for manufacturers and end users of biologics, advanced diagnostics, durable medical equipment, and capital goods.
For more information, visit venturemedical1.com and follow us on LinkedIn
About Open Wound Research: Open Wound Research is committed to making wound care research simpler to conduct, reproducible, and actionable for wound care stakeholders. This is accomplished by fusing clinical, research, and data science competencies to build research and data pipelines that deliver on sponsors’ needs and vision. We are also committed to open-sourcing wound care data and software to foster transparency, participation and collaboration in wound care research.
For more information, visit openwoundresearch.com.
Popular Posts
Categories
The price patients will pay for the PFS
After a recent survey we conducted, it is clear most clinicians agreed skin substitutes are highly effective and essential, warning that the proposed rates would reduce patient access, hinder innovation, and threaten the viability of many practices. Read the blog to learn more about our findings.
The Case For Mobile Wound Care: An Essential Component Of Chronic Wound Management
Mobile wound care is a critical yet often misunderstood part of chronic wound management, providing advanced treatment to patients who can't easily access traditional care. Far from being a fringe service, it’s a large and growing field—with nearly 30,000 clinicians billing for mobile wound services in 2023 alone—and plays a key role in addressing the rising burden of chronic wounds, especially in nursing homes. As wound severity increases, staffing shortages persist, and the population ages, mobile providers are filling care gaps through high-volume, high-quality services and innovative tools like AI-assisted telehealth and near-infrared spectroscopy. To ensure better outcomes and lower healthcare costs, policymakers and payers must recognize mobile wound care as an essential, professional solution—not a peripheral one.
Venture Position on CMS and MAC Skin Substitute Proposals
Venture Medical, LCC is sharing our position on the CY2026 Medicare Physician Fee Schedule and our future recommendations.
How CMS Fudged the Math:
If we want reimbursement systems that reflect real-world care and outcomes, we need to speak up. The comment period is now open. Read the full breakdown from John Schroeder and Howard Walthall to learn more about how you can join the call for fair, evidence-based reimbursement.
Venture Medical Leads Investment in Plasmacure to Advance Breakthrough Cold Plasma Technology for Chronic Wound Healing
Venture Medical announces the closing of a strategic investment in Plasmacure B.V., the Dutch MedTech innovator behind PLASOMA, an award-winning cold plasma therapy for complex wound healing.
Venture Medical Announces Acquisition of Select ProgenaCare Global Assets to Expand Advanced Wound Care Portfolio
Venture Medical Announces Acquisition of Select ProgenaCare Global Assets to Expand Advanced Wound Care Portfolio
